Home > Journal >>Instructions for authors

Manuscript submission:

Manuscripts re to be submitted electronically via manuscript submission system…..

Editorial decision:

Submitted manuscripts undergo initial editorial reviewing for the formatting style, and appropriateness to the journal scope. Articles that pass the initial editorial screening are sent to the reviewers.

Evaluation of the manuscript includes a combined editorial and external peer-review process. Decisions are made based on the quality of submitted manuscripts including novelty of the idea/hypothesis, reliability of data, appropriateness of interpretation of findings, validity of results and conclusions. Ethical aspects, language and presentation, clinical implications, relevance to the journal´s readership and overall priority will also be taken into account during the decision making process.

Language, style, and format::

Articles should be submitted in concise scientific English. It is the responsibility of the submitting authors to send their article in correct English language.

Cover letter: :

In a cover letter authors should introduce the material sent to the journal, and comment on its appropriateness for the journal.

For clinical trials involving intervention, authors must provide the trial registration number and the name of the publicly accessible registry in which the trial has been registered.

Please include specific information on ethical committee/institutional review board approval (e.g. name of the ethical committee, reference number and date of approval) Authors should also inform the Editors of any special circumstances or details regarding the submitted material, including prior submission/publication of the material or parts of the material to another journal or another language.

In case the manuscript has been reviewed elsewhere before this submission, please include the reviews and your responses to prior criticism.

A paragraph in the Cover Letter explaining each author's contribution is required.

Original Research Article:
Manuscript structure:

Title page, Conflicts of Interest statement, Abstract, Keywords, Abbreviations, Key Message, Main text, including; Introduction, Material and methods, Results, and Discussion, Acknowledgments, Funding Statement, References, Legends of Tables and Figures, and Tables and/or Figures.

• Title page – should include:

a) full title of the article (title should be descriptive, clear, concise and incorporate keywords/phrases without using abbreviations or proprietary names)

b) running headline (for page heading, max 49 characters), Publishing fees of 30 Egyptian pounds per page are to be paid after acceptance.

c) all contributing authors with full name (first name, middle name(s), and surname followed by degrees, and

d) Authors’ affiliation(s) (institution, town and country) in English. Affiliations are marked with superscript numbers. Provide separately the corresponding author (only one) details to whom all decision letters and page proofs will be communicated (give the professional address and include telephone with country code and e-mail).

• Conflicts of Interest notification:

All authors must state explicitly whether potential conflicts of interest do or do not exist on a separate page following the title page. Authors are responsible for disclosing all financial and personal relationships that could be viewed as presenting a potential conflict of interest.

• Abstract –

A structured abstract of no more than 250 words is required, subdivided into the following sequential sections: Introduction, Material and Methods, Results, and Conclusions.

• Keywords –

include 5-8 keywords for indexing services and other search facilities for published material. Standardized medical subject headings (MeSH terms) are preferred.

• Abbreviations –

Provide a list of abbreviations used in the text after the key words. Use only widely accepted and conventional abbreviations. If an abbreviation appears four times or less in the manuscript it should not be used.

• Key Message –

Provide a key message from the article, which will be published in a box at the front of the article. This should contain one to three short sentences (maximum of 40 words) phrased differently from the conclusion. Emphasize the main problem targeted and to what degree it was solved or new knowledge was added.

• Main text -

The text should be 1000-3000 words and structured with the following headings (bold, lower case): Introduction (including hypothesis, aims and objectives), Material and methods(including information on consent, ethics approval and statistical analysis), Results andDiscussion (including interpretation of main findings, validity of results, strengths and limitations of the study and conclusion). Subheadings should be limited except when describing complicated methodology.

• Introduction –

Provide a relevant background and introduce the problem being investigated citing key published work. Clearly state the purpose or objective of the research and what questions are to be addressed or answered – preferably in one page or less.

• Material and methods

The design of investigations, methods of analysis, source of data and outcome measures should be described in sufficient detail to permit the study to be repeated by others and must include specification of all statistical methods. See also EQUATOR reporting guidelines on www.Equator-network.org.

Present methods of statistical analyses and, when appropriate, power calculations in a separate subdivision or paragraph. State what statistical methods were used for different parts of the study and give details of test values as appropriate. Cite statistical software programs used. Express probability values (p, small letter in italics) to no more than three decimals after the first 0 before the decimal point (such as 0.001). Confidence intervals (CI) should be reported using a semi-colon and with a dash between values (such as CI; 1.84-3.26), and in tables they should be in a separate marked column. Write “percent” in one word or use %. In tables use the % mark above a column or percentage values and avoid internal brackets/parentheses in the tables. For mathematical equations use italic type for variables and single letters and write them on a single line if possible.

Measurements should be expressed in SI units with the exception of blood pressure (mmHg). See also the IUB Biochemical Nomenclature on http://www.chem.qmw.ac.uk/iubmb/ for further information.

Decimals should be indicated by points (not commas) after the whole number (for example 0.5; 0.001) and thousands by an extra space for figures over 9999, but not by commas or points (for example 1000, 20 500). Generic names of drugs should be used unless a proprietary name is directly relevant. Any specialized equipment, chemical or pharmaceutical product cited in the text must be accompanied by the manufacturer's web-address. This section should also state details of ethical committee (institutional review board) approval (including relevant reference numbers and approval dates) and study participants´ informed consent. For the clinical trials involving intervention, authors must provide the trial registration number and the name of the publicly assessable registry it is registered in.

• Results –

Present the findings in appropriate detail. Duplication between text and tables or figures should be avoided. Related subject matters should be joined in paragraphs (avoid one sentence paragraphs).

• Discussion –

Raise implications of the findings reported and compare them with those of earlier reports. The focus of this section should be the importance of the actual main findings to clinicians and patient care. It may be helpful in developing arguments to reiterate some of the findings, but avoid repetition of results given earlier in the article. A complete review of the literature is not necessary, nor to restate in detail findings from other studies. Strengths and limitations of the study should be discussed. A final concise summary (conclusions) in one short paragraph at the end of discussion can be helpful. Although some degree of speculation is permissible, avoid unfounded conclusions.

• Acknowledgments -

Persons who have made a valuable contribution but do not meet thecriteria for authorship should be listed in an acknowledgments section at the end of the manuscript. Use plain language and avoid adjectives.

• Funding -

Financial and material support must be acknowledged. Grant bodies and major financial contributors should be listed. If no specific funding was obtained, this should also be stated.

• References -

The ‘Vancouver style’ of references must be applied (straight variety). No more than 30 references are accepted as a general rule.

Faculty Page on Facebook


Click here

Faculty Page on Twitter


Click here

Faculty Page on Google+


Click here

Faculty Page on Youtube


Click here